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This work evaluated the Fenton process in the removal of eight pharmaceuticals 
(gemfibrozil, nimesulide, furosemide, paracetamol, propranolol, dipyrone, fluoxetine, 
and diazepam), present at an initial concentration of 500 µg L-1 for each compound, 
from three different water matrixes (distilled water, simulated wastewater, and hospital 
wastewater). The Fenton process conditions (iron and hydrogen peroxide 
concentrations, and pH) were optimized for the distilled water matrix by Doehlert 
design associated with response surface methodology. These corresponded to an initial 
Fe
2+
 concentration of 12.5 mg L-1, an initial hydrogen peroxide concentration of 533 mg 
L-1, and pH 5.0. Mineralization rates and pharmaceutical degradation were monitored 
for all water matrixes and different experimental conditions employed. Unique iron 
addition, using low iron concentration (12.5 mg L-1) and increased iron concentration 
(37.5 mg L-1) were evaluated. These preliminary results motivated the study of the 
Fenton process employing successive iron additions and using an excess of hydrogen 
peroxide in the reaction medium. Multiple iron addition favored higher oxidation of the 
initial contaminants. Finally, the most persistent transformation products generated 
during the Fenton process were identified by liquid chromatography coupled with 
quadrupole-time of flight mass spectrometry (UHPLC-QTOF MS) using a purpose-built 
database that allowed monitoring of 97 transformation products, simultaneously, in one 
chromatographic analysis only. In this study, 12 transformation products (TPs) were 
tentatively identified employing this purpose-built database. Most TPs generated were 







 Pharmaceuticals can be considered one of the most important groups of 
unregulated micropollutants, especially by the increase in the use of these substances, 
and by the enhanced limits of detection of these compounds due to the impressive 
advance in some analytical tools, such as chromatographic techniques coupled with 
mass spectrometry. These compounds may be candidates for future regulation, 
depending on the results of research into their effects on human health and aquatic 
biota, and on follow-up data regarding the frequency of their presence in the 
environment. Is known that pharmaceuticals do not need to persist in the environment to 
cause negative effects, since the high rates of transformation or removal that they are 
able to undergo can be offset by their continuous introduction into the environment 
(Barceló, 2003).  
 Recent studies have detected more than 80 compounds with pharmacological 
activity in different environmental aqueous matrixes at concentrations ranging from 
ng L-1 to μg L-1 (Ibáñez et al., 2017; Carraro et al., 2016; Marković et al., 2015; Lin et 
al., 2010; Mendoza et al., 2015; Santos et al., 2013; Gómez et al., 2007; Roberts and 
Thomaz, 2006; Lishman et al., 2006; Andreozzi et al., 2003; Sedlak et al., 2005; Lacey 
et al., 2008; Sui et al., 2010; Spongberg and Witter, 2008; Santos et al., 2005; Bueno et 
al., 2007; Kim et al., 2007; Gros et al., 2006; Ternes et al., 2001a; Ternes et al., 2001b; 
Farré et al., 2001; Metcalfe et al., 2004; Castiglioni et al., 2005; Bartelt-Hunt et al., 
2009; Escher et al., 2011). Moreover, according to these studies, the highest levels of 
pharmaceuticals are found near sewage spillways (Heberer, 2002).  
In this context, special attention should be given to hospital effluents, which are 
characterized by high concentrations of pharmaceuticals and metabolites, disinfectants, 
pigments/dyes, reagents, etc. (Gupta et al., 2009; Langford and Thomas, 2009). In 
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general, hospital effluents have an extra contribution of organic content that favors high 
COD, low BOD and, therefore, biological processes conventionally used are not 
suitable for the treatment of these hospital wastewaters (Elmolla and Chaudhuri, 2009; 
Rahim Pouran et al., 2015). According to Carraro et al. (2016) in only a few countries is 
hospital effluent classified as industrial wastewater, and because of its characteristics 
goes through some kind of pre-treatment before discharge into the sewage system. 
In this sense, Advanced Oxidation Processes (AOPs) represent an option that has 
proven effective for the treatment of water contaminated with organic compounds. 
These processes are characterized by the generation of hydroxyl radicals, a highly 
oxidizing species, at atmospheric pressure and at room temperature. The high potential 
of AOPs for the treatment of water containing pharmaceuticals is widely recognized 
(Klavarioti et al., 2009; Giannakis et al., 2015). Among the different PAOs, photo-
Fenton and Fenton processes have been shown to be good options for removal of 
pharmaceuticals from different effluents and environmental or water matrixes (Miralles-
Cuevas et al., 2014a and 2014b; Rahim Pouran et al., 2015; Mirzaei et al., 2017; Li et 
al., 2012; Wilde et al., 2017; Perini et al., 2018). 
The Fenton process combines H2O2 and Fe
2+ as reactants (reactions 1 and 2) to 
produce hydroxyl radicals and other transient species that can oxidize a wide range of 
organic compounds. For the classical Fenton process, a more restricted pH control is 
necessary and for this reason this treatment process was traditionally performed at acid 
pH (2.5–3) (Gallard et al., 1998). However, now there are some studies demonstrating 
the possibility of working with near-neutral pHs. These studies emphasize the 
importance of working with almost neutral pH for practical applications of these 
treatment processes. Two interesting examples of manuscripts where this subject has 
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been properly highlighted were published by Vermilye and Volker (2009) and Clarizia 
et al. (2017). 
  (1) 
 (2) 
Generally, in the Fenton process, organic compounds are oxidized by hydroxyl 
radicals and other reactive transient species, but are not completely mineralized, 
favoring generation of transformation products (TPs) (Ostra et al., 2007). The TPs 
formed can present numerous possible chemical structures because there is no 
previously defined favored path. The TPs are only identifiable through the use of 
advanced chromatographic techniques, mainly high-resolution mass spectrometry 
coupled to liquid chromatography (LC-HRMS) (Gago-Ferrero et al., 2016). There is no 
doubt that there are many studies in the literature that aim at identification of TPs during 
different AOP treatment processes (Gupta and Garg, 2018; Fatta-Kassinos et al., 2011; 
García-Galán et al., 2016; Jallouli et al., 2016). However, in these studies, only ideal 
conditions are considered: just one model compound was employed, at significantly 
higher initial concentrations than those found in natural or raw waters and wastewaters 
(at mg L-1), and using distilled water as matrix. All these conditions are quite different 
from those found in real effluents where numerous pharmaceuticals, metabolites and 
TPs are present in low concentrations in complex aqueous matrixes.  
In view of the above, this work aims, for the first time, to optimize the 
experimental conditions of a Fenton process using Doehlert design and, afterwards, to 
evaluate the influence of three different water matrixes – distilled water (DW), 
simulated wastewater (SW), and raw hospital wastewater (RHW) – to treat, 
simultaneously, eight pharmaceuticals at µg L-1 concentrations, by a Fenton process. As 
a final step, this study intends to identify the major TPs generated during the Fenton 
process by liquid chromatography coupled with quadrupole-time of flight mass 
  OHOHFeOHFe 322
2






spectrometry (UHPLC-QTOF MS), employing a new purpose-built database that 
allowed tentative identification of 97 TPs in one chromatographic analysis. 
 
2. Material and methods 
2.1 Chemicals, solutions and water matrixes 
All reagents used for chromatographic analyses were LC-MS grade. Acetonitrile 
(ACN) and methanol (MeOH) and formic acid (purity = 98%) were purchased from 
Merck (Darmstadt, Germany) and from Scharlau (Barcelona, Spain). Ammonium 
acetate LC-MS grade was purchase from Fluka, Sigma-Aldrich (Germany). All 
pharmaceuticals included in this work were purchased from different providers and 
were analytical grade (purity > 98.99%). Fenton experiments were performed using iron 
sulfate heptahydrate (FeSO4·7H2O) purchased from Reagen (Rio de Janeiro, Brazil). 
Reagent-grade hydrogen peroxide (H2O2, 39% w/v) and sulfuric acid (H2SO4, 98%) 
used for pH adjustment were purchased from Synth (São Paulo, Brazil). 
Eight pharmaceuticals selected were employed with individual initial average 
concentrations below 500 µg L-1: gemfibrozil (GFZ), nimesulide (NMD), furosemide 
(FRS), paracetamol (PCT), propranolol (PPN), dipyrone (DIP), fluoxetine (FXT) and 
diazepam (DZP). Working solutions were prepared by appropriate dilution of the stock 
solutions that were prepared using analytical standards of the selected pharmaceuticals 
and MeOH/ACN, 1:2 (v/v). The choice of these pharmaceuticals was due to the fact that 
most of them are consumed continuously or in specific cases without medical 
prescription (analgesics). Moreover, the existence of national regulations in Brazil that 
control the acquisition and manipulation of many drugs led to the selection of the 
compounds mentioned above.  
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Experiments were carried out in three different water matrixes: DW, SW, and 
RHW. The composition of SW was from the method reported by the OECD (1999) to 
simulate the organic content of the real hospital wastewater employed in this work 
(Composition for 1L of SW: peptone 160 mg L-1, beef extract 110 mg L-1, urea 30 mg 
L-1, Mg2SO4·7H2O 2 mg L
-1, CaCl2·2H2O 4 mg L
-1). The RHW used in this study came 
from a public hospital located in the city of Porto Alegre (Brazil). Its main 
characteristics were: pH 7.85, chloride 35.7 mg L-1, conductivity 691.3 μS cm-1, BOD 
130.3 mg L-1 O2, DOC 72.9 mg L
-1, COD 291 mg L-1 O2, phosphate 13.98 mg L
-1, total 
suspended solids 85.3 mg L-1, and total solids 378 mg L-1. RHW consisted of raw 
hospital wastewater, which was used as it came (without filtration) in degradation 
studies. 
 
2.2 Fenton process 
Fenton experiments were performed in a borosilicate-glass vessel (1L) equipped 
with magnetic stirring. During the reaction, the system was protected from light. For 
this, the reaction was carried out in a black box with total insulation and, in addition, the 
system was covered with black polymeric material. This material did not come into 
contact with the treated solution and only guaranteed extra protection from radiation. 
The optimization of Fenton reaction conditions was carried out using Doehlert designs.  
In all experiments, pH was adjusted using H2SO4, and H2O2 (39% w/v) was 
added only at the beginning of the experiments. For Fe(II) two different approaches 
were evaluated: a single dose of Fe2+ at the beginning of the treatment process, and 
other successive iron additions at different times during the treatment. The selected 
pharmaceuticals were added (as described in Section 2.1), to each water matrix, before 




2.3 Analytical Determinations during Fenton Process 
Mineralization was followed by measuring the dissolved organic carbon (DOC) 
by Analytik Jena AG multi N/C 2100 S. Total iron concentration was monitored using 
colorimetric determination with 1,10-phenanthroline, following ISO 6332 (1988), using 
a UV-vis Cary 50 spectrophotometer. Hydrogen peroxide was analyzed by a 
spectrophotometric method using ammonium metavanadate, based on the formation of a 
red-orange peroxovanadium cation during the reaction of H2O2 with metavanadate 
(Nogueira et al., 2005). Monitoring of the degradation of the selected pharmaceuticals 
was performed by the reduction of the chromatographic peak area (A/A0) in UHPLC-
QTOF MS at different treatment times.  
 
2.4 UHPLC-QTOF MS instrumentation 
Pharmaceutical TPs generated during the Fenton process were monitored, for the 
first time, at Federal University of Rio Grande do Sul (UFRGS-Brazil) by an UHPLC 
system (Shimadzu Nexera X2) connected to a QTOF mass spectrometer (Bruker 
Daltonics, Impact II). The UHPLC was equipped with a reverse-phase Luna®Omega 
C18 analytical column (2.1 mm × 50 mm × 1.6 μm). When ionization in positive mode 
was selected, the mobile phase was a mixture of MeOH acidified with 0.1% formic acid 
(A) and H2O acidified with 0.1% formic acid (B) at a flow rate of 0.28 mL/min. In this 
case, the gradient progressed from 10% A (initial conditions) to 90% A in 10 min, and 
then maintained for 2 min. The QTOF mass spectrometer was operated in positive 
ionization mode under the following conditions: capillary 4000 V, nebulizer 40 psi, 
drying gas 9 L/min, gas temperature 200 °C. In turn, when the analysis was conducted 
in negative ionization mode, the mobile phase employed was composed by a mixture of 
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methanol acidified with 0.01% formic acid (A) and water acidified with 0.01% formic 
acid (B) at a flow rate of 0.28 mL/min. The same gradient as applied in positive mode 
was used. The QTOF mass spectrometer was operated in negative ionization mode 
under the following conditions: capillary 2500 V, nebulizer 40 psi, drying gas 9 L/min, 
gas temperature 190 °C. In all analyses, the injection volume was 10 μL. The samples 
injected were previously filtered through a 0.22 µm PVDF filter. The QTOF MS system 
was operated in broadband collision-induced dissociation (bbCID) acquisition mode 
that provided MS and MS/MS spectra at the same time. All MS information was 
recorded over the m/z range of 50−1000 with a scan rate of 2 Hz. The bbCID mode 
allowed for work with two different collision energies: one with a Low Collision 
Energy (LE) of 10 eV, and a second that applies a High Collision Energy (HE) of 20 eV 
to obtain MS/MS spectra. Data from TP analysis were processed with DataAnalysis 4.2 
software. Elemental composition and double-bond equivalent (RDB) were selected. In 
most cases, possible elemental compositions for ions with a deviation of ±5 ppm of 
error were assigned. 
In a second moment, due to the higher complexity of the hospital wastewater 
and difficulties associated with the identification of compounds, the TPs generated 
during the Fenton process in RHW were also analyzed in University Jaume I (UJI-
Spain) in order to complement the present study. A Waters Acquity UHPLC system 
(Waters, Milford, MA, USA) coupled to a hybrid quadrupole-orthogonal acceleration-
TOF mass spectrometer (XEVO G2 QTOF, Waters Micromass, Manchester, UK), using 
an orthogonal Z-spray-ESI interface was used, operating in both positive and negative 
ionization modes. The chromatographic separation was performed using an Acquity 
UHPLC BEH C18 analytical column (2.1 mm × 100 mm × 1.7 μm) from Waters. The 
mobile phase employed was composed by a mixture of methanol acidified with 0.01% 
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formic acid (A) and water acidified with 0.01% formic acid (B), at a flow rate of 300 
µL/min. The initial percentage of A was 10%, which was linearly increased to 90% in 
14 min, followed by a 2 min isocratic period, and then returned to initial conditions over 
2 min. The QTOF MS was operated in both ionization modes under the following 
conditions: capillary voltages of 700 (ESI+) and 2000 V (ESI-), cone voltage of 20 V, 
desolvation temperature set to 600 °C, the source temperature to 130 °C and the column 
temperature to 40 °C. In all analyses, the injection volume was 25 μL. The samples 
injected were previously filtered through a 0.22 µm filter.  
For MSE experiments, two acquisition functions with different collision energies 
were selected. The low energy function (LE), selecting a collision energy of 4 eV, and 
the high energy (HE) function, with a collision energy ramp ranging from 15 to 40 eV 
were used, in order to obtain a greater range of fragment ions. The LE and HE functions 
settings were both for a scan time of 0.4 s. Mass data was acquired with MassLynx v 
4.1 (Waters) and all data were processed by ChromaLynx application manager (within 
MassLynx v 4.1). In all cases, possible elemental compositions for ions with a deviation 
of 2 mDa were assigned. 
 
2.5 Predicted biodegradability and the toxicological risk of TPs 
Toxtree software (version 2.6.13) was used to evaluate the predicted 
biodegradability (START biodegradability) and the toxicological risk (Cramer rules) of 
the TPs tentatively identified. 
 
 
3. Results and Discussion 
3.1 Doehlert design 
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In this study, the Doehlert design was applied to optimize experimental Fenton 
conditions, such as Fe2+ and H2O2 concentrations and pH, using DW matrix. Initial 
average concentration for each selected pharmaceutical was below 500 µg L-1 and the 
initial solution was prepared according was described in Section 2.1.  
Multivariate models, such as the Doehlert model, are second-order experimental 
designs, which are more complete than univariate models, since they allow the study of 
several variables simultaneously (Ferreira et al., 2004). This model reduces the number 
of experiments to be performed and it is used in conjunction with multivariate statistic 
techniques such as response surface methodology (RSM). This approach is very useful 
to optimize reaction conditions, and is based on the fit of a polynomial equation to the 
experimental data, to describe the behavior of a data set aiming at statistical previsions 
(Bezerra et al., 2008). The levels evaluated for each variable are presented in Table 1. 
 
Table 1. Variables and levels tested in Doehlert design and their respective responses as 
mineralization (%) after 60 minutes for DW matrix. 
Fe2+ levels (mg L-1) 
-1 -0.5 0 0.5 1 
5.0 7.5 10.0 12.5 15.0 
H2O2 levels (mg L-1) 
-0.866 -0.577 -0.289 0 0.289 0.577 0.866 
100 208 316 425 533 641 750 
pH levels 
-0.817 0 0.817 









after 60 min) 
1 15.0 425.0 3.9 23.7 
2 12.5 750.0 3.9 22.0 
3 12.5 533.5 5.0 27.3 
4 5.0 425.0 3.9 19.3 
5 7.5 100.0 3.9 4.3 
6 7.5 316.5 2.8 7.5 
7 12.5 100.0 3.9 5.6 
8 12.5 316.5 2.8 13.5 
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9 7.5 750.0 3.9 7.5 
10 10.0 641.5 2.8 20.8 
11 7.5 533.5 5.0 9.3 
12 10.0 208.5 5.0 9.0 
13 10.0 425.0 3.9 20.2 
14 10.0 425.0 3.9 24.4 
15 10.0 425.0 3.9 23.4 
16 10.0 425.0 3.9 21.0 
 
Sixteen experiments were required by the Doehlert design. The mineralization 
percentage achieved in the Fenton reaction after 60 min was used as experimental 
response. The optimum conditions for the Fenton process were achieved with 12.5 mg 
L-1 of Fe2+, 533 mg L-1 of H2O2, and pH 5 (test number 3). The obtained data were used 
in RSM and the visualization of the predicted model was obtained in the graphical 
representation of the relationship between pH and H2O2 concentration (see Equation 1 
and Figure 1). This illustrates the profile in the optimization of the two variables where 
the maximum point is located within the experimental region, a relationship deemed to 
be important since both the concentration of hydrogen peroxide and pH are main factors 
for the Fenton process. The quality of the adjusted model was assessed by Analysis of 
Variance (ANOVA), allowing for the evaluation of the significance of the regression. 
This verification was carried out using electronic spreadsheets (Teófilo et al., 2006) to 
show whether the mathematical model was well adjusted to the experimental data. All 
results obtained from the Doehlert design are presented in supplementary information 
(Tables S.1.1, S.1.2, Figures S.1.1, S.1.2 and S.1.3). In this case, the present model 
explained more than 88% of the experimental data. There was a good strong match 
between the model’s predicted sensibility efficiency values and the experimental values. 
For this reason, the optimized experimental conditions (test number 3) were selected to 
evaluate Fenton reaction performance to degrade pharmaceuticals in the three water 





+ ( -0.014800799)*(y(j)^2) + ( -6.48633116)*((x(i))*(y(j)))   (Equation 1) 
 
 
Figure 1. Response surface for H2O2 and pH interaction.  
 
3.2. Single iron addition  
The Fenton process was carried out at pH 5.0, using a single Fe2+ addition that 
corresponded to 12.5 mg L-1 and an initial H2O2 concentration of 533.5 mg L
-1 (see 
Figure 2) in the three matrixes studied. The results showed that some pharmaceuticals 
were eliminated after 1 min of treatment. In this case, DIP and FRS showed the highest 
degradation rate in DW and SW. These data are in agreement with studies by Klamerth 
et al., (2013), where FRS exhibits rapid degradation in the first minutes of the treatment 
process. On the other hand, NMD, FXT, DZP and GFZ were more persistent in all 
matrixes evaluated.  
Experiments performed in DW showed a reduction of 27% in the initial DOC 
after 120 min. In turn, SW did not present significant mineralization until the final 
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treatment time period monitored. At this stage, for SW and RHW, 5% and 3% of the 
initial DOC was reached, respectively. Besides, at this point, for both these water 
matrixes – SW and RHW – initial H2O2 consumed was 258 mg L
-1 and 270 mg L-1, 
respectively. In all cases, 533 mg L-1 of H2O2 was used to provide an excess and to 
avoid limiting the reaction. Iron(II) remained practically constant during the Fenton 
reaction in all water matrixes studied when a single dose of iron was used (see Figure 
3). Our results for H2O2 and iron(II) are in agreement with data reported by Carra et al. 
(2013) for dark Fenton and where Fenton was evaluated and compared to solar photo-
Fenton processes.  
 For RHW, it is important consider that the presence of some pharmaceuticals in 
this real wastewater was to be expected. Thus, in order to evaluate whether the model 
pharmaceuticals were already present in this matrix, another study was performed and is 
the subject of other manuscript that now is in preparation. These preliminary analyses 
indicated that paracetamol, dipyrone and diazepam are the only pharmaceuticals that 
were presented in the RHW matrix. However, since the degradation of these and other 
drugs selected for study was monitored by the reduction of the peak area in relation to 
the initial area, the efficiency of the treatment process took into account the potential 
additional loading of these three analytes. 
In this context, it is important to highlight that in this study it was decided to 
carry out the direct injection of initial and degraded samples from all water matrixes 
evaluated; that is, no extraction and/or pre-concentration method was performed in the 
present study. This option aimed to provide minimum manipulation of the samples, and 
thus reduce the possibility of losses of the initial pharmaceuticals and, principally, their 
TPs. Additionally, according Togolla et al. (2014), Solid Phase Extraction (SPE) 
techniques are therefore used, but require large quantities of samples, and in our case, as 
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the experiments were performed in batch and with an initial volume of 1L, these 







Figure 2. Pharmaceuticals degradation during the Fenton process using single iron 
addition (Fe2+ 12.5 mg L-1; H2O2 533 mg L





Figure 3. Total iron, H2O2 consumption and DOC/DOC0 ratio determined during 
Fenton process for three different water matrixes evaluated using single iron addition 
(Fe2+ 12.5 mg L-1; H2O2 533 mg L
-1 and pH 5). 
 
The discrete efficiency of the Fenton process in RHW and, especially in SW 
matrixes, could be justified by the presence of organic matter and different ionic species 
(Sirtori et al., 2010). Also, according to Bang et al. (2016), the presence of natural 
organic matter has a negative effect on the removal of some compounds. In their study, 
the authors demonstrated that the removal was inversely proportional to the TOC 
concentration in the synthetic water used in their study. Thus, the presence of natural 
organic matter caused a significant increase in energy consumption, due to the strong 
absorption properties and the high reactivity with OH radicals in the treatment process 
evaluated by the authors. In our results, the effect of the water matrix composition on 
the pharmaceutical degradation during the Fenton process was quite prominent. 
















































































In this context, according to Zhang et al. (2016) and García-Muñoz et al. (2017), 
pharmaceuticals are much more reactive than the other organic content present in 
complex wastewaters (real or simulated) during different advanced treatment processes. 
Moreover, Lanzafame et al. (2017) demonstrated that different ions commonly found in 
wastewater, such as chloride or carbonate among others, can act as scavengers of the 
hydroxyl radicals and lead to the formation of species such as Cl2•
– and CO3•
– 
(significantly less reactive than the hydroxyl radical). This would lead to lower 
degradation of pharmaceuticals in SW. In addition, the presence of phosphate could lead 
to decreasing iron solubility, due to the increase in inter-ionic forces in the solution, 
decreasing the efficiency of the treatment process. In this case, RHW contains 
13.98 mg L-1 of phosphates, unlike the SW matrix which does not contain phosphate.  
Thus, in order to increase the efficiency of the process, the single addition assay 
was repeated using an initial concentration of iron at 37.5 mg L-1, maintaining the initial 
H2O2 at 533 mg L
-1 (since it had already been added in excess and was only partially 
consumed after 120 min of treatment) and pH 5. Only DW matrix was evaluated with a 
higher initial concentration of iron (37.5 mg L-1) and the results are shown in Figure 4. 
In this case it is observed that the increase in iron(II) concentration from 12.5 to 37.5 
mg L-1 as initial single addition favored the increase of the mineralization by 12%. On 
the other hand, when multiple iron(II) additions (with a total final concentration of 37.5 
mg L-1 of Fe (II)) was tested, 39% of the initial organic content was mineralized. These 





Figure 4. Total iron, H2O2 consumption and DOC/DOC0 ratio determined during 
Fenton process for DW matrix using single addition (Fe2+ 12.5 mg L-1) and single 
addition (Fe2+ 37.5 mg L-1) and multiple iron addition (Fe2+ 37.5 mg L-1). All 




3.3 Multiple iron additions  
In an attempt to improve pharmaceutical degradation by the Fenton process, 
multiple iron(II) additions were made with the same initial H2O2 concentration of 533 
mg L-1, based on studies of sequential iron dosage as a strategy for the successful 
removal of environmental pollutants at neutral pH (Carra et al., 2013). Different iron 
dosages were performed (0 min: 12.5 mgL-1; 5 min: 6.25 mgL-1; 10 min: 6.25 mgL-1; 15 
min: 6.25 mgL-1; 25 min: 6.25 mgL-1) for a total iron dose of 37.5 mg L-1. This strategy 
was evaluated because, as is known, the periodic addition of iron(II) to the water 
maintains a stable catalyst concentration (ferrous ions), reflected in superior efficiency 
of the treatment process.  
DIP, FRS and PPN showed the highest degradation rate in the three matrixes 
(Figure 5), and they exhibited rapid degradation in the initial treatment time range. On 
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the other hand, PCT, NMD, FXT, DZP and GFZ were more persistent in RHW. It 
seems that increasing the concentration of iron available in the system by successive 
iron additions favors the formation of hydroxyl radicals, as long as there is an excess of 
hydrogen peroxide in the reaction medium. Consequently, a greater degree of oxidation 
of the contaminants was achieved.  
Experiments performed in DW matrix showed a DOC reduction of 40% after 
120 min. In turn, SW and RHW presented a moderated mineralization (around 15%) 
until the final treatment time period monitored (see Figure 6). At the final treatment 
time, H2O2 consumption was 225.2, 328.4 and 223.8 mg L
-1 for DW, SW and RHW, 
respectively. Iron concentration was reduced by 10% only at 120 min for RHW (final 










Figure 5. Pharmaceuticals degradation during the Fenton process using multiple iron 
additions (Fe2+  37.5mg L-1; H2O2  533 mg L







Figure 6. Total iron, H2O2 consumption and DOC determined during Fenton process 
for three different water matrixes evaluated using multiple iron additions (Fe2+ 37.5mg 
L-1; H2O2 533 mg L
-1 and pH 5). 
 
3.4 Transformation Products  
In order to detect the presence of possible TPs formed, samples from each 
experiment were analyzed by a UHPLC-QTOF MS instrument operating in positive and 
negative ionization modes, as previously described in Section 2.4. A purpose-built 
database containing a total of 97 TPs reported in the literature for the eight 
pharmaceuticals under study was elaborated. The purpose-built database included the 
elemental composition of the TPs as well as information about the product ions reported 
for these species, if available (for more details, see Table S.2.1 - Supporting 
Information).  
It is important to note that, in general, in studies where transformation products 
are proposed, as mentioned in the introduction, only one drug is normally used at high 
initial concentrations (in the order of tens of mg L-1). These individual studies 
performed with individual pharmaceuticals are extremely useful because they bring 
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valuable data that were used as a data source for the purpose-built database. Thus, once 
the purpose-built database was elaborated, the data processing was adapted from other 
previous studies that used this tool to qualitatively identify the presence of different 
compounds (such as pharmaceuticals, pesticides, metabolites, among others, with or 
without analytical standard available) (Hernández et al., 2014; Díaz et al., 2013). Thus, 
as far as is known, the elaboration and use of a purpose-built database for tentative 
identification of different TPs generated by AOPs is a new strategy that allows the 
degradation of pharmaceuticals simultaneously and in concentrations closer to those 
found in hospital effluents (Mendoza et al., 2015). For this reason, it can be considered 
that the present work, by bringing this additional aspect of the use of the purpose-built 
database, from an analytical point of view, provides a new application for an automated 
method for the search for TPs.  
Table 2 summarizes the analytical information relative to the TPs identified in 
all water matrixes studied, such as elemental composition, theoretical and experimental 
accurate masses of the ions, their respective errors in ppm and double bond equivalents 
(DBE) provided by the software. The low mass errors observed (below 5ppm in most 
cases), allowed for the correct assignation of the elemental compositions. 
 
Table 2. TPs identified during the Fenton process treatment by UHPLC-QTOF MS 















TP3 PPN C6H16NO2 134.1175 134.1176 0.4 0.5 P DW 
 C6H14NO 116.1069 116.1070 -0.3 0.5   
 C6H12N 98.0974 98.0964 -9.5 1.5   
 C3H8NO 74.0603 74.0600 -1.5 0.5   
 C4H10N 72.0807 72.0808 0.6 0.5   
 C3H6N 56.0492 56.0495 4.7 1.5   
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TP6 PPN C16H22NO4 292.1545 292.1543 -0.7 6.5 P DW, SW, 
RHW 
 C10H7O2 159.0422 159.0441 11.7 7.5   
 C9H7O 131.0490 72.0808 -4.1 0.5   
 C6H14NO 116.1067 116.1070 2.8 0.5   
 C8H7 103.0536 103.0542 5.8 5.5   
 C6H12N 98.0968 98.0964 -4.3 1.5   
 C4H10N 72.0806 72.0808 1.9 0.5   
 C3H6N 56.0496 56.0495 -2.9 1.5   
TP7 PPN C14H20NO4 266.1394 266.1387 -1.7 5.5 P DW, SW, 
RHW 
 C6H12N 98.0969 98.0964 -4.7 1.5   
 C3H8NO 74.0610 74.0600 -13.1 0.5   




C14H20NO5 282.1340 282.1336 -1.4 5.5 P DW, SW, 
RHW 
 C6H14NO 116.107 116.107 0.3 0.5   
 C6H12N 98.0969 98.0964 -4.6 1.5   
 C4H10N 72.0811 72.0808 -4.0 0.5   
 C5H6N 56.0495 56.0495 -0.6 1.5   
TP26 PPN C16H22NO5 308.1501 308.1492 -2.8 6.5 P DW, SW, 
RHW 
 C9H7O2* 147.0456* 147.0446* 6.8* 6.5*   
 C6H14NO 116.1072 116.1070 -1.5 0.5   
 C4H10N 72.0811 72.0808 -4.1 0.5   
 C3H6N 56.0491 56.0495 5.9 1.5   
TP1 FXT C17H19F3NO2 326.1368 326.1362 -1.4 7.5 P DW, RHW 
 C10H14NO 164.1067 164.1070 1.5 4.5   
 C9H9O 133.0657 133.0648 -6.9 5.5   
 C3H7O 59.0493 59.0491 -2.9 0.5   
TP1 NMD C13H11N2O6S 323.0333 323.0343 3.2 9.5 N DW, RHW 
 C12H9N2O4 245.0563 245.0568 1.9 9.5   
 C10H4N3O2S 229.9993 230.0030 16.0 10.5   
TP6 PCT C8H8NO5 198.0404 198.0408 1.8 5.5 N DW 
 C8H5O5 181.0136 181.0142 3.5 6.5   
 C7H8NO3 154.0526 154.0510 -10.5 4.5   
 C6H6NO3 140.0355 140.0353 -1.4 4.5   
TP1 GFZ C15H21O4 265.1481 265.1445 -13.3 5.5 N DW, RHW 
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TP3 GFZ C8H9O2 137.0606 137.0608 1.7 4.5 N DW 
TP7 GFZ C15H19O4 263.1277 263.1289 4.6 6.5 N DW 
 C8H9O 121.0670 121.0659 -9.2 4.5   
TP8 GFZ C9H9O3 165.0580 165.0557 -14.1 5.5 N DW 
* For more information see Figure S 2.2 (supporting information).  
 
As it has been previously indicated, only those by-products that had been 
previously reported in the literature were sought (Santiago-Morales et al., 2013; Zhao et 
al., 2017; Sun et al., 2016; Moctezuma et al., 2012; Najjar et al., 2014; Chen et al., 
2017). Likewise, in this study, the data processing to identify some TPs was adapted 
with some modifications from Ibáñez et al. (2017) and Llorca et al. (2016). An 
automatic screening for peak detection was performed, and a mass error of the 
suspected TPs (± 5ppm) was used. As shown in Table 2, 12 TPs were found in the 
matrixes studied.  
As Table 2 shows, four TPs were identified in the three types of water tested, 
three more TPs were identified in DW and RHW only, and four TPs were found in DW 
only. The fact that more TPs were present in DW might be explained by the formation 
of a greater number of OH radicals, which in turn provided a greater degradation and 
mineralization of the pharmaceuticals. Consequently, a greater number of TPs were 
detected in that matrix. In addition, the composition of the other matrixes could favor 
ion suppression effects that would have an effect on the lower number of TPs observed 
for SW and RHW. 
According to our results, a total of five TPs were found for PPN (see Figure 
S.2.1). Of these, three (TP3 PPN, TP6 PPN and TP7 PPN) could be associated with 
photocatalytic by-products using Ce-doped TiO2 as catalyst, as reported by Santiago-
Morales et al. (2013). The fourth of the TPs (m/z 282.1336 Da, C14H20NO5) could not be 
fully elucidated because two isomeric compounds were plausible (TP5 PPN or TP19 
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PPN). Both of them present similar fragmentation, with few specific characteristic 
fragments. Unfortunately, specific fragments of the suspected TPs were not observed, 
making it to unfeasible to identify which of the two TPs was involved. 
The last PPN TP corresponded to m/z 308.1492 Da, with an elemental 
composition C16H22NO5. It might correspond to TP26 PPN or TP27 PPN. In this case, 
the complementary QTOF analysis performed at UJI allowed for the identification of 
the characteristic signal fragment (m/z 147.0446, C9H7O2) of TP26 PPN. Accurate mass 
spectra obtained for TP26 PPN at high collision energy are shown in Figure S 2.2 
(Supporting Information). 
Regarding FXT, only one TP was observed. TP1 FXT exhibited an m/z of 
326.1368 Da, corresponding to the elemental composition C17H19F3NO2. This TP had  
been previously identified by Zhao et al. (2017) as an intermediate product 
generated after ozonation processes at different pHs. In that study, the authors also 
indicated that generation of this hydroxylated TP was enhanced with increasing pH, by 
increasing the concentration of hydroxyl radicals in the alkaline medium of the 
treatment process. 
In addition to the TPs discussed above, and identified in positive mode, six more 
TPs were identified in negative ionization mode: one for NMD and PCT and four for 
GFZ. TP1 NMD showed an accurate mass of 323.0338 Da, corresponding to an 
elemental composition of C13H11N2O6S (expressed as deprotonated molecule). This 
hydroxylated metabolite was one of the major compounds observed in human plasma 
by Sun et al. (2016), after administration of NMD. Thus, it seems that this metabolite 
can also be considered a transformation product from the Fenton degradation. 
In the case of paracetamol, the identified TP was TP6 PCT (m/z 198.0404 Da, 
C8H8NO5). This TP was previously identified as a transformation product generated by 
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photocatalytic degradation (UV–TiO2) (Moctezuma et al., 2012) and ozonation, or a 
UV–H2O2 TP of PCT in aqueous medium (Najjar et al., 2014). 
For the GFZ, four identified TPs (TP1 GFZ, TP3 GFZ, TP7 GFZ and TP8 GFZ) 
were by-products previously found by Cheng et al. (2017) in the degradation of 
gemfibrozil by photocatalysis mediated by sunlight-driven TiO2 (carbon dots 
photocatalyst). These TPs showed reduced fragmentation, even when employing high 
collision-energy HE, as can be seen in Figure S.2.1. 
It is possible that other TPs could have been produced during treatment with the 
Fenton process in all matrixes evaluated. However, they were not detected definitively 
due to their low persistence throughout the process, or to their formation in very small 
concentrations. It must be pointed out that analyses were made by direct injection of the 
samples, without any type of pre-concentration, in order to minimize potential losses of 
TPs of different polarities associated with the sample treatment. 
 Finally, tentatively identified TPs were evaluated by Toxtree software (version 
2.6.13), which determined, based on predictions of the chemical structure of the 
molecule to be analyzed, the biodegradability (START biodegradability) and the 
toxicological risk (Cramer rules) that each TP offers. This strategy was previously 
employed by Urbano et al. (2017) for toxicity and biodegradability determination of 
some TPs of sulfaquinoxaline generated by an ozonation process. The results obtained 
by the Toxtree software for TPs tentatively identified in the present study can be seen in 
Table 3.  
The transformation products TP6 PPN, TP1 FXT, TP1 NMD, TP6 PCT, and 
TP3 GFZ were classified as highly toxic according to Cramer's rules. These TPs are 
substances that have significant toxicity, or still have reactive functional groups. In turn, 
TP1 GFZ has been classified as of intermediate toxicity; that is, it is clearly less 
 
 27 
innocuous than those of Class I, but does not provide either a positive indication of 
toxicity, or a lack of those characteristics in Class III. Finally, TP3 PPN, TP7 PPN, TP7 
GFZ and TP8 GFZ were classified as Class I. Compounds classified as Class I are 
substances with those structures and related data suggesting a low order of oral toxicity. 
If combined with low human exposure, they should not present a particular priority for 
research (Cramer et al., 1978). 
Evaluating the biodegradability of the different TPs it was observed that TP3 
PPN, TP6 PPN, TP1 FXT and TP1 NMD were classified as persistent substances. The 
other TPs (TP7 PPN, TP6 PCT, TP1 GFZ, TP3 GFZ, TP7 GFZ and TP8 GFZ) which 
were present in greater amounts, in turn, were considered to be readily biodegradable. 
This capability of the Fenton process, and of AOPs in general, to favor the formation of 
more biodegradable substances is an important aspect already reported in previous 
studies (Sirtori et al., 2010; Zapata et al., 2010). 
 
Table 3. Toxicological risk (Cramer rules) and START biodegrability determined by 
the TPs generated during Fenton process. 

















































































In this work, the optimum experimental conditions to perform the Fenton 
process on three different waster matrixes containing eight pharmaceuticals were 
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achieved using a Doehlert model. For the DW matrix, the treatment process using 
increased and multiple Iron(II) additions studied showed an efficient mineralization rate 
and degradation of the selected pharmaceuticals. A less favorable behavior was 
observed for the other matrixes under study (SW and RHW). The purpose-built 
database containing up to 97 TPs was elaborated for analysis of the samples by 
UHPLC-QTOF MS. This allowed identification of 12 TPs generated during the Fenton 
process, making use of the accurate masses and fragmentation behavior. Most TPs 
identified were hydroxylation products of the pharmaceuticals initially present, and 
these compounds were classified as high toxicity (Cramer rules). Finally, the 
biodegradability assessment (START biodegradability) indicated that most TPs 
generated by the Fenton process are readily biodegradable. 
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